Paper32922012
Extracellular Vesicles - Advanced Nanocarriers in Cancer Therapy: Progress and Achievements.
Huyan T and 6 others. Int J Nanomedicine, 2020. Cited by 60 papers, by iCite.
Cite this record
ConductScience Library. Extracellular Vesicles - Advanced Nanocarriers in Cancer Therapy: Progress and Achievements. Papers, record 32922012. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32922012
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Extracellular Vesicles - Advanced Nanocarriers in Cancer Therapy: Progress and Achievements.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Drug Carriers | Major topic |
| Extracellular Vesicles | Major topic |
| Nanoparticles | Major topic |
| Neoplasms | Major topic |
| Antineoplastic Agents | |
| Drug Delivery Systems | |
| Humans |
Source PubMed
References141
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30964695 | Genetically Engineered Cell Membrane Nanovesicles for Oncolytic Adenovirus Delivery: A Versatile Platform for Cancer Virotherapy. | Nano Lett | 2019 | https://conductscience.org/library/papers/30964695 | PubMed |
| 2 | 30927973 | Stem cell damage after chemotherapy- can we do better? | Best Pract Res Clin Haematol | 2019 | https://conductscience.org/library/papers/30927973 | PubMed |
| 3 | 29448215 | Synthesis of dual temperature - and pH-responsive yolk-shell nanoparticles by conventional etching and new deswelling approaches: DOX release behavior. | Colloids Surf B Biointerfaces | 2018 | https://conductscience.org/library/papers/29448215 | PubMed |
| 4 | 23090506 | siRNA-based therapeutic approaches for rheumatic diseases. | Nat Rev Rheumatol | 2013 | https://conductscience.org/library/papers/23090506 | PubMed |
| 5 | 28202367 | Exosomes: Therapy delivery tools and biomarkers of diseases. | Pharmacol Ther | 2017 | https://conductscience.org/library/papers/28202367 | PubMed |
| 6 | 29721412 | Exosome-Liposome Hybrid Nanoparticles Deliver CRISPR/Cas9 System in MSCs. | Adv Sci (Weinh) | 2018 | https://conductscience.org/library/papers/29721412 | PubMed |
| 7 | 30530866 | Apoptosis and apoptotic body: disease message and therapeutic target potentials. | Biosci Rep | 2019 | https://conductscience.org/library/papers/30530866 | PubMed |
| 8 | 30951627 | Exosomes as Drug Carriers for Cancer Therapy. | Mol Pharm | 2019 | https://conductscience.org/library/papers/30951627 | PubMed |
| 9 | 25220352 | Surface functionalization of exosomes using click chemistry. | Bioconjug Chem | 2014 | https://conductscience.org/library/papers/25220352 | PubMed |
| 10 | 29085024 | Bioinspired Cell-Derived Nanovesicles versus Exosomes as Drug Delivery Systems: a Cost-Effective Alternative. | Sci Rep | 2017 | https://conductscience.org/library/papers/29085024 | PubMed |
| 11 | 28495994 | Methodological Guidelines to Study Extracellular Vesicles. | Circ Res | 2017 | https://conductscience.org/library/papers/28495994 | PubMed |
| 12 | 25713383 | Differential fates of biomolecules delivered to target cells via extracellular vesicles. | Proc Natl Acad Sci U S A | 2015 | https://conductscience.org/library/papers/25713383 | PubMed |
| 13 | 25849885 | Low pH increases the yield of exosome isolation. | Biochem Biophys Res Commun | 2015 | https://conductscience.org/library/papers/25849885 | PubMed |
| 14 | 28435469 | Interleukin 3- receptor targeted exosomes inhibit in vitro and in vivo Chronic Myelogenous Leukemia cell growth. | Theranostics | 2017 | https://conductscience.org/library/papers/28435469 | PubMed |
| 15 | 26477404 | Microvesicles released from tumor cells disrupt epithelial cell morphology and contractility. | J Biomech | 2016 | https://conductscience.org/library/papers/26477404 | PubMed |
| 16 | 24493004 | Microfluidic fabrication of cell-derived nanovesicles as endogenous RNA carriers. | Lab Chip | 2014 | https://conductscience.org/library/papers/24493004 | PubMed |
| 17 | 25836593 | Exosomes as drug delivery vehicles for Parkinson's disease therapy. | J Control Release | 2015 | https://conductscience.org/library/papers/25836593 | PubMed |
| 18 | 29372017 | Therapeutic biomaterials based on extracellular vesicles: classification of bio-engineering and mimetic preparation routes. | J Extracell Vesicles | 2018 | https://conductscience.org/library/papers/29372017 | PubMed |
| 19 | 30517011 | In Vitro and in Vivo RNA Inhibition by CD9-HuR Functionalized Exosomes Encapsulated with miRNA or CRISPR/dCas9. | Nano Lett | 2019 | https://conductscience.org/library/papers/30517011 | PubMed |
| 20 | 25899407 | Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting. | J Extracell Vesicles | 2015 | https://conductscience.org/library/papers/25899407 | PubMed |
Cited by48
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 60 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42282125 | Migrasomes program tissue microenvironment: from physiology to oncology, future perspectives in clinical advances. | J Natl Cancer Cent | 2026 | https://conductscience.org/library/papers/42282125 | PubMed |
| 41998363 | Titanium dioxide nanoparticles in oncology: synthesis, application, and challenges. | Cell Biol Toxicol | 2026 | https://conductscience.org/library/papers/41998363 | PubMed |
| 41562261 | Research progress and application prospect of engineered small extracellular vesicles. | Cell Transplant | 2026 | https://conductscience.org/library/papers/41562261 | PubMed |
| 41450858 | Advancements in plant-derived exosome-like vesicles: Versatile bioactive carriers for targeted drug delivery systems. | J Pharm Anal | 2025 | https://conductscience.org/library/papers/41450858 | PubMed |
| 41205008 | Insights into the Versatile Role of Extracellular Vesicles in the Treatment of CNS Disorders. | Mol Neurobiol | 2025 | https://conductscience.org/library/papers/41205008 | PubMed |
| 40827924 | Lactobacillus crispatus-derived nCEV vesicles promote cutaneous wound healing and inhibit HPV16 infection. | mSystems | 2025 | https://conductscience.org/library/papers/40827924 | PubMed |
| 40739238 | Sonodynamic biomimetic-nanomedicine fight cancers. | J Nanobiotechnology | 2025 | https://conductscience.org/library/papers/40739238 | PubMed |
| 40620684 | Mesenchymal Stem Cell-Derived Extracellular Vesicles: Emerging Therapies for Neurodegenerative Diseases. | Int J Nanomedicine | 2025 | https://conductscience.org/library/papers/40620684 | PubMed |
| 40520644 | Exosomal non-coding RNAs: key molecules in the diagnosis and treatment of coronary artery disease. | PeerJ | 2025 | https://conductscience.org/library/papers/40520644 | PubMed |
| 40366524 | Intranasal Immunotherapy with Allergen-Loaded Extracellular Vesicles from Mast Cells Alleviates Allergic Asthma Inflammation in a Murine Model. | Inflammation | 2025 | https://conductscience.org/library/papers/40366524 | PubMed |
| 40301903 | Progress of mesenchymal stem cell-derived exosomes in targeted delivery of antitumor drugs. | Cancer Cell Int | 2025 | https://conductscience.org/library/papers/40301903 | PubMed |
| 40281600 | Extracellular vesicles as therapeutic modulators of neuroinflammation in Alzheimer's disease: a focus on signaling mechanisms. | J Neuroinflammation | 2025 | https://conductscience.org/library/papers/40281600 | PubMed |
| 40277513 | Innovative Applications of Nanopore Technology in Tumor Screening: An Exosome-Centric Approach. | Biosensors (Basel) | 2025 | https://conductscience.org/library/papers/40277513 | PubMed |
| 40092132 | Application of engineered exosomes in tumor therapy. | Am J Transl Res | 2025 | https://conductscience.org/library/papers/40092132 | PubMed |
| 39997849 | Magnetic Nanoparticles and Drug Delivery Systems for Anti-Cancer Applications: A Review. | Nanomaterials (Basel) | 2025 | https://conductscience.org/library/papers/39997849 | PubMed |
| 39630738 | Nanotechnology in oncology: a mini review. | Rev Assoc Med Bras (1992) | 2024 | https://conductscience.org/library/papers/39630738 | PubMed |
| 39188515 | Exosomes: Toward a potential application in bladder cancer diagnosis and treatment. | Smart Med | 2024 | https://conductscience.org/library/papers/39188515 | PubMed |
| 39118776 | Recent developments in cancer diagnosis and treatment using nanotechnology. | Ann Med Surg (Lond) | 2024 | https://conductscience.org/library/papers/39118776 | PubMed |
| 38794316 | Extracellular Vesicles in Breast Cancer: From Intercellular Communication to Therapeutic Opportunities. | Pharmaceutics | 2024 | https://conductscience.org/library/papers/38794316 | PubMed |
| 38706989 | Harnessing exosomes as a platform for drug delivery in breast cancer: A systematic review for in vivo and in vitro studies. | Mol Ther Oncol | 2024 | https://conductscience.org/library/papers/38706989 | PubMed |
Genes38
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32922012
GET https://conductscience.org/api/papers/v1/32922012/references?page=2